Indeed, over the years accumulating evidence from a number of studies has supported the view that HNF3β genetic alterations or suppression were closely related to the occurrence, progression, or metastasis of several kinds of tumors, including gastric, thyroid, and lung cancer (10, 11, 14). The gene discussed is FOXA2; the disease is lung carcinoma.